https://www.selleckchem.com/pr....oducts/CP-690550.htm
72, p=0.01) and ≥2h second (OR 2.25, p0.01) stage labour, increased likelihood of receiving IV syntocinon (OR 9.38, p0.01), antibiotics (OR 2.97, p0.01) and a greater probability of pyrexia (OR 10.26, p0.01). Women who used EA were half as likely to be breastfeeding at three months postpartum (OR 0.53, p0.01). No differences were observed between groups in neonatal outcomes. Our data shows significant associations between EA use and several intrapartum outcomes. Our data shows significant associations between EA us
Curtir
Comentario
Compartilhar
